Use of N-Phenyl-2-Pyrimidineamine Derivatives against mast cell-based diseases like allergic disorders

Details for Australian Patent Application No. 2002307140 (hide)

Owner Novartis AG The Government of the United States Koike, K. Komiyama, A. Takeuchi, K. Oregon Health and Science University

Inventors Komiyama, Atsushi; Heinrich, Michael; Nakajima, Motowo; Koike, Kenichi; Takeuchi, Kovichi

Agent Davies Collison Cave

Pub. Number AU-B-2002307140

PCT Number PCT/US02/10742

PCT Pub. Number WO2002/080925

Priority 0108606.5 05.04.01 GB

Filing date 5 April 2002

Wipo publication date 21 October 2002

Acceptance publication date 16 February 2006

International Classifications

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61P 37/08 (2006.01) Drugs for immunological or allergic disorders

Event Publications

19 December 2002 Complete Application Filed

  Priority application(s): 0108606.5 05.04.01 GB

10 April 2003 Application Open to Public Inspection

  Published as AU-B-2002307140

16 February 2006 Application Accepted

  Published as AU-B-2002307140

15 June 2006 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002307141-Method and system for analysing chromatograms

2002307139-SEGMENTED BALLOON CATHETER BLADE